{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:40:37Z","timestamp":1792615237791,"version":"4.5.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02831-0","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:51:44Z","timestamp":1750063904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tumor-associated neutrophils and neutrophil extracellular traps in lung cancer: antitumor\/protumor insights and therapeutic implications"],"prefix":"10.1007","volume":"42","author":[{"given":"Milad","family":"Sheervalilou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Ghanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Arabfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2831_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/07357907.2022.2119479","volume":"41","author":"F Abu Rous","year":"2023","unstructured":"Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Lung cancer treatment advances in 2022. Cancer Investig. 2023;41:12\u201324. https:\/\/doi.org\/10.1080\/07357907.2022.2119479.","journal-title":"Cancer Investig"},{"key":"2831_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2831_CR3","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, et al. National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data. Lancet Public Heal. 2023;8:e943\u201355. https:\/\/doi.org\/10.1016\/S2468-2667(23)00211-6.","journal-title":"Lancet Public Heal"},{"key":"2831_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115891","volume":"169","author":"Y Li","year":"2023","unstructured":"Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169: 115891. https:\/\/doi.org\/10.1016\/j.biopha.2023.115891.","journal-title":"Biomed Pharmacother"},{"key":"2831_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3892\/ijo.2024.5684","volume":"65","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liang J, Zhang Y, Guo Q. Drug resistance and tumor immune microenvironment: an overview of current understandings (Review). Int J Oncol. 2024;65:96. https:\/\/doi.org\/10.3892\/ijo.2024.5684.","journal-title":"Int J Oncol"},{"key":"2831_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.938289","volume":"10","author":"M Yan","year":"2022","unstructured":"Yan M, Zheng M, Niu R, Yang X, Tian S, Fan L, et al. Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications. Front Cell Dev Biol. 2022;10: 938289. https:\/\/doi.org\/10.3389\/fcell.2022.938289.","journal-title":"Front Cell Dev Biol"},{"key":"2831_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/ndt\/gfad266","volume":"39","author":"D Maier-Begandt","year":"2023","unstructured":"Maier-Begandt D, Alonso-Gonzalez N, Klotz L, Erpenbeck L, Jablonska J, Immler R, et al. Neutrophils\u2014biology and diversity. Nephrol Dial Transplant. 2023;39:1551\u201364. https:\/\/doi.org\/10.1093\/ndt\/gfad266.","journal-title":"Nephrol Dial Transplant"},{"key":"2831_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-051222-015009","volume":"19","author":"A Aroca-Crevill\u00e9n","year":"2024","unstructured":"Aroca-Crevill\u00e9n A, Vicanolo T, Ovadia S, Hidalgo A. Neutrophils in physiology and pathology. Annu Rev Pathol Mech Dis. 2024;19:227\u201359. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-051222-015009.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2831_CR9","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/s41590-024-02006-5","volume":"25","author":"R Herro","year":"2024","unstructured":"Herro R, Grimes HL. The diverse roles of neutrophils from protection to pathogenesis. Nat Immunol. 2024;25:2209\u201319. https:\/\/doi.org\/10.1038\/s41590-024-02006-5.","journal-title":"Nat Immunol"},{"key":"2831_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-024-01786-4","volume":"9","author":"C Silvestre-Roig","year":"2024","unstructured":"Silvestre-Roig C, Kalafati L, Chavakis T. Neutrophils are shaped by the tumor microenvironment: novel possibilities for targeting neutrophils in cancer. Signal Transduct Target Ther. 2024;9:77. https:\/\/doi.org\/10.1038\/s41392-024-01786-4.","journal-title":"Signal Transduct Target Ther"},{"key":"2831_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12032-023-02010-z","volume":"40","author":"S Lenka","year":"2023","unstructured":"Lenka S, Bhola RK, Varanasi PR, Bhuyan SK, Bhuyan R. Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC. Med Oncol. 2023;40:134. https:\/\/doi.org\/10.1007\/s12032-023-02010-z.","journal-title":"Med Oncol"},{"key":"2831_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104588","volume":"379","author":"R Yang","year":"2022","unstructured":"Yang R, Wang X, Ma C, Zhang Z, Liu N, Ma X, et al. Tumor-infiltrating neutrophils and peripheral neutrophil-to-lymphocyte ratio conversely predicted the prognosis of patients with non-small cell lung cancer. Cell Immunol. 2022;379: 104588. https:\/\/doi.org\/10.1016\/j.cellimm.2022.104588.","journal-title":"Cell Immunol"},{"key":"2831_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","volume":"40","author":"A Hidalgo","year":"2019","unstructured":"Hidalgo A, Chilvers ER, Summers C, Koenderman L. The neutrophil life cycle. Trends Immunol. 2019;40:584\u201397. https:\/\/doi.org\/10.1016\/j.it.2019.04.013.","journal-title":"Trends Immunol"},{"key":"2831_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","volume":"125","author":"RC Furze","year":"2008","unstructured":"Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology. 2008;125:281\u20138. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02950.x.","journal-title":"Immunology"},{"key":"2831_CR15","doi-asserted-by":"publisher","first-page":"eaat4579","DOI":"10.1126\/sciimmunol.aat4579","volume":"3","author":"K Ley","year":"2018","unstructured":"Ley K, Hoffman HM, Kubes P, Cassatella MA, Zychlinsky A, Hedrick CC, et al. Neutrophils: new insights and open questions. Sci Immunol. 2018;3:eaat4579. https:\/\/doi.org\/10.1126\/sciimmunol.aat4579.","journal-title":"Sci Immunol"},{"key":"2831_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","volume":"50","author":"JM Adrover","year":"2019","unstructured":"Adrover JM, del Fresno C, Crainiciuc G, Cuartero MI, Casanova-Acebes M, Weiss LA, et al. A neutrophil timer coordinates immune defense and vascular protection. Immunity. 2019;50:390-402.e10. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.002.","journal-title":"Immunity"},{"key":"2831_CR17","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.3390\/cells11244076","volume":"11","author":"W Loh","year":"2022","unstructured":"Loh W, Vermeren S. Anti-inflammatory neutrophil functions in the resolution of inflammation and tissue repair. Cells. 2022;11:4076. https:\/\/doi.org\/10.3390\/cells11244076.","journal-title":"Cells"},{"key":"2831_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","volume":"25","author":"SJ Allen","year":"2007","unstructured":"Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25:787\u2013820. https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090529.","journal-title":"Annu Rev Immunol"},{"key":"2831_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: a chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther. 2021;219: 107692. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107692.","journal-title":"Pharmacol Ther"},{"key":"2831_CR20","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/2211-5463.13445","volume":"12","author":"K He","year":"2022","unstructured":"He K, Liu X, Hoffman RD, Shi RZ, Lv GY, Gao JL. G-CSF\/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors. FEBS Open Bio. 2022;12:1268\u201385. https:\/\/doi.org\/10.1002\/2211-5463.13445.","journal-title":"FEBS Open Bio"},{"key":"2831_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1126\/science.abj2674","volume":"377","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yan J, Tao Y, Qian X, Zhang C, Yin L, et al. Pituitary hormone a-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science (80-). 2022;377:1085\u201391. https:\/\/doi.org\/10.1126\/science.abj2674.","journal-title":"Science (80-)"},{"key":"2831_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.it.2016.03.006","volume":"37","author":"S Nourshargh","year":"2016","unstructured":"Nourshargh S, Renshaw SA, Imhof BA. Reverse migration of neutrophils: Where, when, how, and why? Trends Immunol. 2016;37:273\u201386. https:\/\/doi.org\/10.1016\/j.it.2016.03.006.","journal-title":"Trends Immunol"},{"key":"2831_CR23","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA. 2012;109:2491\u20136. https:\/\/doi.org\/10.1073\/pnas.1113744109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16:601\u201320. https:\/\/doi.org\/10.1038\/s41571-019-0222-4.","journal-title":"Nat Rev Clin Oncol"},{"key":"2831_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.602963","volume":"12","author":"E McKenna","year":"2021","unstructured":"McKenna E, Mhaonaigh AU, Wubben R, Dwivedi A, Hurley T, Kelly LA, et al. Neutrophils: need for standardized nomenclature. Front Immunol. 2021;12: 602963. https:\/\/doi.org\/10.3389\/fimmu.2021.602963.","journal-title":"Front Immunol"},{"key":"2831_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","volume":"1877","author":"H Que","year":"2022","unstructured":"Que H, Fu Q, Lan T, Tian X, Wei X. Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochim Biophys Acta - Rev Cancer. 2022;1877: 188762. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188762.","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"2831_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, et al. N1 versus N2 and PMN-MDSC: a critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2023;314:250\u201379. https:\/\/doi.org\/10.1111\/imr.13176.","journal-title":"Immunol Rev"},{"key":"2831_CR28","doi-asserted-by":"publisher","first-page":"19083","DOI":"10.1073\/pnas.1905054116","volume":"116","author":"LSC Lok","year":"2019","unstructured":"Lok LSC, Dennison TW, Mahbubani KM, Saeb-Parsy K, Chilvers ER, Clatworthy MR. Phenotypically distinct neutrophils patrol uninfected human and mouse lymph nodes. Proc Natl Acad Sci USA. 2019;116:19083\u20139. https:\/\/doi.org\/10.1073\/pnas.1905054116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR29","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","volume":"9","author":"MT Masucci","year":"2019","unstructured":"Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 2019;9:1146. https:\/\/doi.org\/10.3389\/fonc.2019.01146.","journal-title":"Front Oncol"},{"key":"2831_CR30","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1111\/febs.14524","volume":"285","author":"ME Shaul","year":"2018","unstructured":"Shaul ME, Fridlender ZG. Cancer-related circulating and tumor-associated neutrophils \u2013 subtypes, sources and function. FEBS J. 2018;285:4316\u201342. https:\/\/doi.org\/10.1111\/febs.14524.","journal-title":"FEBS J"},{"key":"2831_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-024-03222-4","volume":"21","author":"J Wen","year":"2024","unstructured":"Wen J, Liu D, Zhu H, Shu K. Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy. J Neuroinflammation. 2024;21:226. https:\/\/doi.org\/10.1186\/s12974-024-03222-4.","journal-title":"J Neuroinflammation"},{"key":"2831_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell. 2009;16:183\u201394. https:\/\/doi.org\/10.1016\/j.ccr.2009.06.017.","journal-title":"Cancer Cell"},{"key":"2831_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2020.00532","volume":"11","author":"M Ohms","year":"2020","unstructured":"Ohms M, M\u00f6ller S, Laskay T. An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro. Front Immunol. 2020;11:532. https:\/\/doi.org\/10.3389\/fimmu.2020.00532.","journal-title":"Front Immunol"},{"key":"2831_CR34","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.3390\/ijms21103457","volume":"21","author":"N Mukaida","year":"2020","unstructured":"Mukaida N, Sasaki SI, Baba T. Two-faced roles of tumor-associated neutrophils in cancer development and progression. Int J Mol Sci. 2020;21:3457. https:\/\/doi.org\/10.3390\/ijms21103457.","journal-title":"Int J Mol Sci"},{"key":"2831_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4132\/jptm.2022.11.06","volume":"57","author":"WA Hassan","year":"2023","unstructured":"Hassan WA, El Banna AK, Noufal N, El-Assmy M, Lotfy H, Ali RI. Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma. J Pathol Transl Med. 2023;57:88\u201394. https:\/\/doi.org\/10.4132\/jptm.2022.11.06.","journal-title":"J Pathol Transl Med"},{"key":"2831_CR36","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317-1334.e10. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.009.","journal-title":"Immunity"},{"key":"2831_CR37","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.3390\/cancers13205082","volume":"13","author":"L Arpinati","year":"2021","unstructured":"Arpinati L, Kaisar-iluz N, Shaul ME, Groth C, Umansky V, Fridlender ZG. Tumor-derived factors differentially affect the recruitment and plasticity of neutrophils. Cancers (Basel). 2021;13:5082. https:\/\/doi.org\/10.3390\/cancers13205082.","journal-title":"Cancers (Basel)"},{"key":"2831_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10:562\u201373. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.039.","journal-title":"Cell Rep"},{"key":"2831_CR39","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1096\/fj.201902467R","volume":"34","author":"ME Shaul","year":"2020","unstructured":"Shaul ME, Eyal O, Guglietta S, Aloni P, Zlotnik A, Forkosh E, et al. Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis. FASEB J. 2020;34:4204\u201318. https:\/\/doi.org\/10.1096\/fj.201902467R.","journal-title":"FASEB J"},{"key":"2831_CR40","doi-asserted-by":"publisher","DOI":"10.3791\/52933","volume":"2015","author":"RV Sionov","year":"2015","unstructured":"Sionov RV, Assi S, Gershkovitz M, Sagiv JY, Polyansky L, Mishalian I, et al. Isolation and characterization of neutrophils with anti-tumor properties. J Vis Exp. 2015;2015: e52933. https:\/\/doi.org\/10.3791\/52933.","journal-title":"J Vis Exp"},{"key":"2831_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485\u201398. https:\/\/doi.org\/10.1038\/s41577-020-00490-y.","journal-title":"Nat Rev Immunol"},{"key":"2831_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.557586","volume":"11","author":"N Karin","year":"2020","unstructured":"Karin N. The development and homing of myeloid-derived suppressor cells: from a two-stage model to a multistep narrative. Front Immunol. 2020;11: 557586. https:\/\/doi.org\/10.3389\/fimmu.2020.557586.","journal-title":"Front Immunol"},{"key":"2831_CR43","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cancers14051236","volume":"14","author":"R Li","year":"2022","unstructured":"Li R, Mukherjee MB, Lin J. Coordinated regulation of myeloid-derived suppressor cells by cytokines and chemokines. Cancers (Basel). 2022;14:1236. https:\/\/doi.org\/10.3390\/cancers14051236.","journal-title":"Cancers (Basel)"},{"key":"2831_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1158\/2326-6066.CIR-19-0326","volume":"8","author":"ELM Joseph","year":"2020","unstructured":"Joseph ELM, Laheurte C, Jary M, Boullerot L, Asgarov K, Gravelin E, et al. Immunoregulation and clinical implications of ANGPT2\/Tie2+ m-MDSC signature in non\u2013small cell lung cancer. Cancer Immunol Res. 2020;8:268\u201379. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0326.","journal-title":"Cancer Immunol Res"},{"key":"2831_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.smim.2016.03.018","volume":"28","author":"K Moses","year":"2016","unstructured":"Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28:187\u201396. https:\/\/doi.org\/10.1016\/j.smim.2016.03.018.","journal-title":"Semin Immunol"},{"key":"2831_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803014","volume":"12","author":"N Tumino","year":"2022","unstructured":"Tumino N, Besi F, Martini S, Di Pace AL, Munari E, Quatrini L, et al. Polymorphonuclear myeloid-derived suppressor cells are abundant in peripheral blood of cancer patients and suppress natural killer cell anti-tumor activity. Front Immunol. 2022;12: 803014. https:\/\/doi.org\/10.3389\/fimmu.2021.803014.","journal-title":"Front Immunol"},{"key":"2831_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2326-6066.CIR-22-0035","volume":"11","author":"S Fu","year":"2023","unstructured":"Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, et al. Syntaphilin regulates neutrophil migration in cancer. Cancer Immunol Res. 2023;11:278\u201389. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0035.","journal-title":"Cancer Immunol Res"},{"key":"2831_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-021-01156-5","volume":"14","author":"JA Park","year":"2021","unstructured":"Park JA, Wang L, Cheung NKV. Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. J Hematol Oncol. 2021;14:142. https:\/\/doi.org\/10.1186\/s13045-021-01156-5.","journal-title":"J Hematol Oncol"},{"key":"2831_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/cas.13909","volume":"110","author":"N Wang","year":"2019","unstructured":"Wang N, Wang Q, Chi J, Xiang F, Lin M, Wang W, et al. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma. Cancer Sci. 2019;110:519\u201329. https:\/\/doi.org\/10.1111\/cas.13909.","journal-title":"Cancer Sci"},{"key":"2831_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211041","volume":"14","author":"Y Kim","year":"2019","unstructured":"Kim Y, Lee D, Lee J, Lee S, Lawler S. Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: a mathematical model. PLoS ONE. 2019;14: e0211041. https:\/\/doi.org\/10.1371\/journal.pone.0211041.","journal-title":"PLoS ONE"},{"key":"2831_CR51","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1101\/gad.350418.123","volume":"37","author":"AU Zezulin","year":"2023","unstructured":"Zezulin AU, Yen D, Ye D, Howell ED, Bresciani E, Diemer J, et al. RUNX1 is required in granulocyte- monocyte progenitors to attenuate inflammatory cytokine production by neutrophils. Genes Dev. 2023;37:605\u201320. https:\/\/doi.org\/10.1101\/gad.350418.123.","journal-title":"Genes Dev"},{"key":"2831_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101866","volume":"40","author":"S Zhang","year":"2024","unstructured":"Zhang S, Sun L, Zuo J, Feng D. Tumor associated neutrophils governs tumor progression through an IL-10\/STAT3\/PD-L1 feedback signaling loop in lung cancer. Transl Oncol. 2024;40: 101866. https:\/\/doi.org\/10.1016\/j.tranon.2023.101866.","journal-title":"Transl Oncol"},{"key":"2831_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.devcel.2024.10.010","volume":"60","author":"Z Tang","year":"2024","unstructured":"Tang Z, Hu J, Li XC, Wang W, Zhang HY, Guo YY, et al. A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression. Dev Cell. 2024;60:379-395.e8. https:\/\/doi.org\/10.1016\/j.devcel.2024.10.010.","journal-title":"Dev Cell"},{"key":"2831_CR54","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1111\/febs.17144","volume":"291","author":"J Guo","year":"2024","unstructured":"Guo J, Shu T, Zhang H, Huang N, Ren J, Lin L, et al. A combined model of serum neutrophil extracellular traps, CD8+ T cells, and tumor proportion score provides better prediction of PD-1 inhibitor efficacy in patients with NSCLC. FEBS J. 2024;291:3403\u201316. https:\/\/doi.org\/10.1111\/febs.17144.","journal-title":"FEBS J"},{"key":"2831_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13361","volume":"56","author":"L Pan","year":"2023","unstructured":"Pan L, Wang B, Chen M, Ma Y, Cui B, Chen Z, et al. Lack of <scp>SIRP<\/scp> -alpha reduces lung cancer growth in mice by promoting anti-tumour ability of macrophages and neutrophils. Cell Prolif. 2023;56: e13361. https:\/\/doi.org\/10.1111\/cpr.13361.","journal-title":"Cell Prolif"},{"key":"2831_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003536","volume":"9","author":"JV Alessi","year":"2021","unstructured":"Alessi JV, Ricciuti B, Alden SL, Bertram AA, Lin JJ, Sakhi M, et al. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer. J Immunother Cancer. 2021;9: 003536. https:\/\/doi.org\/10.1136\/jitc-2021-003536.","journal-title":"J Immunother Cancer"},{"key":"2831_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569671","volume":"11","author":"SM Hammoudeh","year":"2020","unstructured":"Hammoudeh SM, Venkatachalam T, Ansari AW, Bendardaf R, Hamid Q, Rahmani M, et al. Systems immunology analysis reveals an immunomodulatory effect of Snail-p53 binding on neutrophil- and T cell-mediated immunity in KRAS mutant non-small cell lung cancer. Front Immunol. 2020;11: 569671. https:\/\/doi.org\/10.3389\/fimmu.2020.569671.","journal-title":"Front Immunol"},{"key":"2831_CR58","doi-asserted-by":"publisher","first-page":"e000405","DOI":"10.1136\/jitc-2019-000405","volume":"8","author":"KG Mitchell","year":"2020","unstructured":"Mitchell KG, Diao L, Karpinets T, Negrao MV, Tran HT, Parra ER, et al. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort. J Immunother Cancer. 2020;8:e000405. https:\/\/doi.org\/10.1136\/jitc-2019-000405.","journal-title":"J Immunother Cancer"},{"key":"2831_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130850","volume":"4","author":"J Kargl","year":"2019","unstructured":"Kargl J, Zhu X, Zhang H, Yang GHY, Friesen TJ, Shipley M, et al. Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. JCI Insight. 2019;4: e130850. https:\/\/doi.org\/10.1172\/jci.insight.130850.","journal-title":"JCI Insight"},{"key":"2831_CR60","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1172\/JCI77053","volume":"124","author":"EB Eruslanov","year":"2014","unstructured":"Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Investig. 2014;124:5466\u201380. https:\/\/doi.org\/10.1172\/JCI77053.","journal-title":"J Clin Investig"},{"key":"2831_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.lungcan.2007.07.022","volume":"59","author":"G Esendagli","year":"2008","unstructured":"Esendagli G, Bruderek K, Goldmann T, Busche A, Branscheid D, Vollmer E, et al. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer. Lung Cancer. 2008;59:32\u201340. https:\/\/doi.org\/10.1016\/j.lungcan.2007.07.022.","journal-title":"Lung Cancer"},{"key":"2831_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","volume":"30","author":"S Singhal","year":"2016","unstructured":"Singhal S, Bhojnagarwala PS, O\u2019Brien S, Moon EK, Garfall AL, Rao AS, et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 2016;30:120\u201335. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.001.","journal-title":"Cancer Cell"},{"key":"2831_CR63","doi-asserted-by":"publisher","first-page":"1304529","DOI":"10.3389\/fimmu.2023.1304529","volume":"14","author":"R Liu","year":"2023","unstructured":"Liu R, Zhu G, Sun Y, Li M, Hu Z, Cao P, et al. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma. Front Immunol. 2023;14:1304529. https:\/\/doi.org\/10.3389\/fimmu.2023.1304529.","journal-title":"Front Immunol"},{"key":"2831_CR64","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Kojder K, Simi\u0144ska D, Bohatyrewicz R, Gutowska I, Chlubek D, et al. Cc chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors ccr1, ccr2, ccr3, and ccr4. Int J Mol Sci. 2020;21:8412. https:\/\/doi.org\/10.3390\/ijms21218412.","journal-title":"Int J Mol Sci"},{"key":"2831_CR65","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1158\/1078-0432.CCR-16-2047","volume":"23","author":"V Governa","year":"2017","unstructured":"Governa V, Trella E, Mele V, Tornillo L, Amicarella F, Cremonesi E, et al. The interplay between neutrophils and CD8+ T cells improves survival in human colorectal cancer. Clin Cancer Res. 2017;23:3847\u201358. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2047.","journal-title":"Clin Cancer Res"},{"key":"2831_CR66","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon J, Gort-Freitas NA, Kiss M, Bolli E, Messemaker M, Siwicki M, et al. A neutrophil response linked to tumor control in immunotherapy. Cell. 2023;186:1448-1464.e20. https:\/\/doi.org\/10.1016\/j.cell.2023.02.032.","journal-title":"Cell"},{"key":"2831_CR67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22:173\u201387. https:\/\/doi.org\/10.1038\/s41577-021-00571-6.","journal-title":"Nat Rev Immunol"},{"key":"2831_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141\u20137. https:\/\/doi.org\/10.1038\/s41586-022-05400-x.","journal-title":"Nature"},{"key":"2831_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Wei YQ, Wei XW. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15:61. https:\/\/doi.org\/10.1186\/s13045-022-01282-8.","journal-title":"J Hematol Oncol"},{"key":"2831_CR70","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3934\/mbe.2025028","volume":"22","author":"D Lee","year":"2025","unstructured":"Lee D, Oh S, Lawler S, Kim Y. Bistable dynamics of TAN-NK cells in tumor growth and control of radiotherapy-induced neutropenia in lung cancer treatment. Math Biosci Eng. 2025;22:744\u2013809. https:\/\/doi.org\/10.3934\/mbe.2025028.","journal-title":"Math Biosci Eng"},{"key":"2831_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.762729","volume":"8","author":"W Peng","year":"2022","unstructured":"Peng W, Sheng Y, Xiao H, Ye Y, Kwantwi LB, Cheng L, et al. Lung adenocarcinoma cells promote self-migration and self-invasion by activating neutrophils to upregulate notch3 expression of cancer cells. Front Mol Biosci. 2022;8: 762729. https:\/\/doi.org\/10.3389\/fmolb.2021.762729.","journal-title":"Front Mol Biosci"},{"key":"2831_CR72","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","volume":"81","author":"PB Ancey","year":"2021","unstructured":"Ancey PB, Contat C, Boivin G, Sabatino S, Pascual J, Zangger N, et al. GLUT1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy. Cancer Res. 2021;81:2345\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2870.","journal-title":"Cancer Res"},{"key":"2831_CR73","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1080\/21655979.2021.1987820","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Tang B, Hu J, Fang X, Bian H, Han J, et al. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer. Bioengineered. 2021;12:8872\u201384. https:\/\/doi.org\/10.1080\/21655979.2021.1987820.","journal-title":"Bioengineered"},{"key":"2831_CR74","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.immuni.2018.09.020","volume":"49","author":"G Mollaoglu","year":"2018","unstructured":"Mollaoglu G, Jones A, Wait SJ, Mukhopadhyay A, Jeong S, Arya R, et al. The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment. Immunity. 2018;49:764-779.e9. https:\/\/doi.org\/10.1016\/j.immuni.2018.09.020.","journal-title":"Immunity"},{"key":"2831_CR75","doi-asserted-by":"publisher","first-page":"72184","DOI":"10.18632\/oncotarget.12360","volume":"7","author":"M Rakaee","year":"2016","unstructured":"Rakaee M, Busund LT, Paulsen EE, Richardsen E, Al-Saad S, Andersen S, et al. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer. Oncotarget. 2016;7:72184\u201396. https:\/\/doi.org\/10.18632\/oncotarget.12360.","journal-title":"Oncotarget"},{"key":"2831_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI130952","volume":"130","author":"K Mahiddine","year":"2020","unstructured":"Mahiddine K, Blaisdell A, Ma S, Cr\u00e9quer-Grandhomme A, Lowell CA, Erlebacher A. Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils. J Clin Invest. 2020;130:389\u2013403. https:\/\/doi.org\/10.1172\/JCI130952.","journal-title":"J Clin Invest"},{"key":"2831_CR77","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/ijms25052929","volume":"25","author":"D Awasthi","year":"2024","unstructured":"Awasthi D, Sarode A. Neutrophils at the crossroads: unraveling the multifaceted role in the tumor microenvironment. Int J Mol Sci. 2024;25:2929. https:\/\/doi.org\/10.3390\/ijms25052929.","journal-title":"Int J Mol Sci"},{"key":"2831_CR78","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1158\/0008-5472.CAN-17-3614","volume":"78","author":"M Gershkovitz","year":"2018","unstructured":"Gershkovitz M, Caspi Y, Fainsod-Levi T, Katz B, Michaeli J, Khawaled S, et al. TRPM2 mediates neutrophil killing of disseminated tumor cells. Cancer Res. 2018;78:2680\u201390. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3614.","journal-title":"Cancer Res"},{"key":"2831_CR79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","volume":"23","author":"AW Segal","year":"2005","unstructured":"Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197\u2013223. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115653.","journal-title":"Annu Rev Immunol"},{"key":"2831_CR80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature14407","volume":"522","author":"V Finisguerra","year":"2015","unstructured":"Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AAR, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522:349\u201353. https:\/\/doi.org\/10.1038\/nature14407.","journal-title":"Nature"},{"key":"2831_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/mutage\/gep053","volume":"25","author":"N G\u00fcng\u00f6r","year":"2010","unstructured":"G\u00fcng\u00f6r N, Knaapen AM, Munnia A, Peluso M, Haenen GR, Chiu RK, et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis. 2010;25:149\u201354. https:\/\/doi.org\/10.1093\/mutage\/gep053.","journal-title":"Mutagenesis"},{"key":"2831_CR82","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.cell.2021.04.016","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui C, Chakraborty K, Tang XA, Zhou G, Schoenfelt KQ, Becker KM, et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell. 2021;184:3163-3177.e21. https:\/\/doi.org\/10.1016\/j.cell.2021.04.016.","journal-title":"Cell"},{"key":"2831_CR83","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta - Mol Cell Res. 2016;1863:2977\u201392. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.012.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"2831_CR84","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.0019-2805.2003.01794.x","volume":"111","author":"H Kamohara","year":"2004","unstructured":"Kamohara H, Matsuyama W, Shimozato O, Abe K, Gallican C, Hashimoto SI, et al. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology. 2004;111:186\u201394. https:\/\/doi.org\/10.1111\/j.0019-2805.2003.01794.x.","journal-title":"Immunology"},{"key":"2831_CR85","doi-asserted-by":"publisher","first-page":"L298","DOI":"10.1152\/ajplung.2001.280.2.l298","volume":"280","author":"KL Serrao","year":"2001","unstructured":"Serrao KL, Fortenberry JD, Owens ML, Harris FL, Brown LAS. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am J Physiol - Lung Cell Mol Physiol. 2001;280:L298-305. https:\/\/doi.org\/10.1152\/ajplung.2001.280.2.l298.","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"2831_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953195","volume":"13","author":"D Scozzi","year":"2022","unstructured":"Scozzi D, Liao F, Krupnick AS, Kreisel D, Gelman AE. The role of neutrophil extracellular traps in acute lung injury. Front Immunol. 2022;13: 953195. https:\/\/doi.org\/10.3389\/fimmu.2022.953195.","journal-title":"Front Immunol"},{"key":"2831_CR87","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0241-2021","volume":"31","author":"HR Keir","year":"2022","unstructured":"Keir HR, Chalmers JD. Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. Eur Respir Rev. 2022;31: 210241. https:\/\/doi.org\/10.1183\/16000617.0241-2021.","journal-title":"Eur Respir Rev"},{"key":"2831_CR88","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3389\/fimmu.2019.00704","volume":"10","author":"AM Brandsma","year":"2019","unstructured":"Brandsma AM, Bondza S, Evers M, Koutstaal R, Nederend M, Marco Jansen JH, et al. Potent Fc receptor signaling by IgA leads to superior killing of cancer cells by neutrophils compared to IgG. Front Immunol. 2019;10:704. https:\/\/doi.org\/10.3389\/fimmu.2019.00704.","journal-title":"Front Immunol"},{"key":"2831_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.semcancer.2012.12.002","volume":"23","author":"M Van Egmond","year":"2013","unstructured":"Van Egmond M, Bakema JE. Neutrophils as effector cells for antibody-based immunotherapy of cancer. Semin Cancer Biol. 2013;23:190\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2012.12.002.","journal-title":"Semin Cancer Biol"},{"key":"2831_CR90","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/0008-5472.CAN-23-2135","volume":"84","author":"S Singhal","year":"2024","unstructured":"Singhal S, Rao AS, Stadanlick J, Bruns K, Sullivan NT, Bermudez A, et al. Human tumor-associated macrophages and neutrophils regulate antitumor antibody efficacy through lethal and sublethal trogocytosis. Cancer Res. 2024;84:1029\u201347. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2135.","journal-title":"Cancer Res"},{"key":"2831_CR91","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.celrep.2018.05.082","volume":"23","author":"HL Matlung","year":"2018","unstructured":"Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, et al. Neutrophils kill antibody-opsonized cancer cells by trogoptosis. Cell Rep. 2018;23:3946-3959.e6. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.082.","journal-title":"Cell Rep"},{"key":"2831_CR92","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1182\/blood-2016-08-735605","volume":"129","author":"R Valgardsdottir","year":"2017","unstructured":"Valgardsdottir R, Cattaneo I, Klein C, Introna M, Figliuzzi M, Golay J. Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies. Blood. 2017;129:2636\u201344. https:\/\/doi.org\/10.1182\/blood-2016-08-735605.","journal-title":"Blood"},{"key":"2831_CR93","doi-asserted-by":"publisher","first-page":"21704","DOI":"10.1073\/pnas.1907660116","volume":"116","author":"C Hagerling","year":"2019","unstructured":"Hagerling C, Gonzalez H, Salari K, Wang CY, Lin C, Robles I, et al. Immune effector monocyte\u2013neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer. Proc Natl Acad Sci USA. 2019;116:21704\u201314. https:\/\/doi.org\/10.1073\/pnas.1907660116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR94","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/npjbcancer.2016.9","volume":"2","author":"E Comen","year":"2016","unstructured":"Comen E, Wojnarowicz P, Seshan VE, Shah R, Coker C, Norton L, et al. TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. Npj Breast Cancer. 2016;2:16009. https:\/\/doi.org\/10.1038\/npjbcancer.2016.9.","journal-title":"Npj Breast Cancer"},{"key":"2831_CR95","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia F, Hashimoto A, Dweep H, Sanseviero E, de Leo A, Tcyganov E, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med. 2021;218: e20201803. https:\/\/doi.org\/10.1084\/JEM.20201803.","journal-title":"J Exp Med"},{"key":"2831_CR96","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/14728222.2021.1954162","volume":"25","author":"TM Bui","year":"2021","unstructured":"Bui TM, Yalom LK, Sumagin R. Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance. Expert Opin Ther Targets. 2021;25:573\u201383. https:\/\/doi.org\/10.1080\/14728222.2021.1954162.","journal-title":"Expert Opin Ther Targets"},{"key":"2831_CR97","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.3390\/cancers15133327","volume":"15","author":"L Gibellini","year":"2023","unstructured":"Gibellini L, Borella R, Santacroce E, Serattini E, Boraldi F, Quaglino D, et al. Circulating and tumor-associated neutrophils in the era of immune checkpoint inhibitors: dynamics, phenotypes, metabolism, and functions. Cancers (Basel). 2023;15:3327. https:\/\/doi.org\/10.3390\/cancers15133327.","journal-title":"Cancers (Basel)"},{"key":"2831_CR98","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI37223","volume":"120","author":"J Jablonska","year":"2010","unstructured":"Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S. Neutrophils responsive to endogenous IFN-\u03b2 regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Investig. 2010;120:1151\u201364. https:\/\/doi.org\/10.1172\/JCI37223.","journal-title":"J Clin Investig"},{"key":"2831_CR99","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ijc.29444","volume":"137","author":"CF Wu","year":"2015","unstructured":"Wu CF, Andzinski L, Kasnitz N, Kr\u00f6ger A, Klawonn F, Lienenklaus S, et al. The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung. Int J Cancer. 2015;137:837\u201347. https:\/\/doi.org\/10.1002\/ijc.29444.","journal-title":"Int J Cancer"},{"key":"2831_CR100","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neo.2014.08.013","volume":"16","author":"EI Deryugina","year":"2014","unstructured":"Deryugina EI, Zajac E, Juncker-Jensen A, Kupriyanova TA, Welter L, Quigley JP. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia (United States). 2014;16:771\u201388. https:\/\/doi.org\/10.1016\/j.neo.2014.08.013.","journal-title":"Neoplasia (United States)"},{"key":"2831_CR101","doi-asserted-by":"publisher","first-page":"20262","DOI":"10.1073\/pnas.0706438104","volume":"104","author":"VC Ardi","year":"2007","unstructured":"Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA. 2007;104:20262\u20137. https:\/\/doi.org\/10.1073\/pnas.0706438104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR102","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.1073\/pnas.0601807103","volume":"103","author":"H Nozawa","year":"2006","unstructured":"Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 2006;103:12493\u20138. https:\/\/doi.org\/10.1073\/pnas.0601807103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR103","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","volume":"179","author":"EM Bekes","year":"2011","unstructured":"Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol. 2011;179:1455\u201370. https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.031.","journal-title":"Am J Pathol"},{"key":"2831_CR104","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1182\/blood-2012-04-421040","volume":"120","author":"G Christoffersson","year":"2012","unstructured":"Christoffersson G, V\u00e5gesj\u00f6 E, Vandooren J, Lid\u00e9n M, Massena S, Reinert RB, et al. VEGF-Arecruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood. 2012;120:4653\u201362. https:\/\/doi.org\/10.1182\/blood-2012-04-421040.","journal-title":"Blood"},{"key":"2831_CR105","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1073\/pnas.0712185105","volume":"105","author":"F Shojaei","year":"2008","unstructured":"Shojaei F, Singh M, Thompson JD, Ferrara N. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA. 2008;105:2640\u20135. https:\/\/doi.org\/10.1073\/pnas.0712185105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR106","doi-asserted-by":"publisher","first-page":"32672","DOI":"10.1074\/jbc.274.46.32672","volume":"274","author":"C Kerkhoff","year":"1999","unstructured":"Kerkhoff C, Klempt M, Kaever V, Sorg C. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J Biol Chem. 1999;274:32672\u20139. https:\/\/doi.org\/10.1074\/jbc.274.46.32672.","journal-title":"J Biol Chem"},{"key":"2831_CR107","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298. https:\/\/doi.org\/10.3389\/fimmu.2018.01298.","journal-title":"Front Immunol"},{"key":"2831_CR108","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ijc.28770","volume":"135","author":"I Mishalian","year":"2014","unstructured":"Mishalian I, Bayuh R, Eruslanov E, Michaeli J, Levy L, Zolotarov L, et al. Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17 - a new mechanism of impaired antitumor immunity. Int J Cancer. 2014;135:1178\u201386. https:\/\/doi.org\/10.1002\/ijc.28770.","journal-title":"Int J Cancer"},{"key":"2831_CR109","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ijc.28957","volume":"136","author":"L Andzinski","year":"2015","unstructured":"Andzinski L, Wu CF, Lienenklaus S, Kr\u00f6ger A, Weiss S, Jablonska J. Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-\u03b2. Int J Cancer. 2015;136:572\u201383. https:\/\/doi.org\/10.1002\/ijc.28957.","journal-title":"Int J Cancer"},{"key":"2831_CR110","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ijc.25892","volume":"129","author":"S Trellakis","year":"2011","unstructured":"Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011;129:2183\u201393. https:\/\/doi.org\/10.1002\/ijc.25892.","journal-title":"Int J Cancer"},{"key":"2831_CR111","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7754\/Clin.Lab.2015.150824","volume":"62","author":"D Zheng","year":"2016","unstructured":"Zheng D, Lin Y, Yu Y, Wang K, Ouyang X, Dang Y, et al. The value of preoperative neutrophil to lymphocyte ratio in indicating lymph node metastasis in patients with resectable T2 stage gastric adenocarcinoma. Clin Lab. 2016;62:659\u201365. https:\/\/doi.org\/10.7754\/Clin.Lab.2015.150824.","journal-title":"Clin Lab"},{"key":"2831_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114803","volume":"194","author":"B Korkmaz","year":"2021","unstructured":"Korkmaz B, Lamort AS, Domain R, Beauvillain C, Gieldon A, Yildirim A\u00d6, et al. Cathepsin C inhibition as a potential treatment strategy in cancer. Biochem Pharmacol. 2021;194: 114803. https:\/\/doi.org\/10.1016\/j.bcp.2021.114803.","journal-title":"Biochem Pharmacol"},{"key":"2831_CR113","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41598-018-36605-8","volume":"9","author":"X Huo","year":"2019","unstructured":"Huo X, Li H, Li Z, Yan C, Agrawal I, Mathavan S, et al. Transcriptomic profiles of tumor-associated neutrophils reveal prominent roles in enhancing angiogenesis in liver tumorigenesis in zebrafish. Sci Rep. 2019;9:1509. https:\/\/doi.org\/10.1038\/s41598-018-36605-8.","journal-title":"Sci Rep"},{"key":"2831_CR114","doi-asserted-by":"publisher","first-page":"1510503","DOI":"10.3389\/fimmu.2025.1510503","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Liu XL, Huang H, Tang M, Li J, Huang T, et al. Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration. Front Immunol. 2025;16:1510503. https:\/\/doi.org\/10.3389\/fimmu.2025.1510503.","journal-title":"Front Immunol"},{"key":"2831_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142277","volume":"308","author":"H Zhang","year":"2025","unstructured":"Zhang H, Sun F, Cao H, Yang L, Yang F, Chen R, et al. UBA protein family: an emerging set of E1 ubiquitin ligases in cancer\u2014a review. Int J Biol Macromol. 2025;308: 142277. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142277.","journal-title":"Int J Biol Macromol"},{"key":"2831_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-015-0164-y","volume":"8","author":"X Liu","year":"2015","unstructured":"Liu X, Xu Y, Pang Z, Guo F, Qin Q, Yin T, et al. Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer. J Hematol Oncol. 2015;8:67. https:\/\/doi.org\/10.1186\/s13045-015-0164-y.","journal-title":"J Hematol Oncol"},{"key":"2831_CR117","doi-asserted-by":"publisher","first-page":"12752","DOI":"10.1002\/jcb.28543","volume":"120","author":"B Jiang","year":"2019","unstructured":"Jiang B, Fan X, Zhang D, Liu H, Fan C. Identifying UBA2 as a proliferation and cell cycle regulator in lung cancer A549 cells. J Cell Biochem. 2019;120:12752\u201361. https:\/\/doi.org\/10.1002\/jcb.28543.","journal-title":"J Cell Biochem"},{"key":"2831_CR118","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/biomedicines10020431","volume":"10","author":"R Poto","year":"2022","unstructured":"Poto R, Cristinziano L, Modestino L, de Paulis A, Marone G, Loffredo S, et al. Neutrophil extracellular traps, angiogenesis and cancer. Biomedicines. 2022;10:431. https:\/\/doi.org\/10.3390\/biomedicines10020431.","journal-title":"Biomedicines"},{"key":"2831_CR119","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jleuko\/qiad004","volume":"113","author":"Y Sheng","year":"2023","unstructured":"Sheng Y, Peng W, Huang Y, Cheng L, Meng Y, Kwantwi LB, et al. Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis. J Leukoc Biol. 2023;113:383\u201399. https:\/\/doi.org\/10.1093\/jleuko\/qiad004.","journal-title":"J Leukoc Biol"},{"key":"2831_CR120","doi-asserted-by":"publisher","first-page":"155479","DOI":"10.1016\/j.cyto.2021.155479","volume":"142","author":"I Karagiannidis","year":"2021","unstructured":"Karagiannidis I, Salataj E, Said Abu Egal E, Beswick EJ. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 2021;142:155479. https:\/\/doi.org\/10.1016\/j.cyto.2021.155479.","journal-title":"Cytokine"},{"key":"2831_CR121","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s10147-024-02541-z","volume":"29","author":"K Tsuchihashi","year":"2024","unstructured":"Tsuchihashi K, Ito M, Okumura Y, Nio K, Ozaki Y, Nishio H, et al. Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology. Int J Clin Oncol. 2024;29:700\u20135. https:\/\/doi.org\/10.1007\/s10147-024-02541-z.","journal-title":"Int J Clin Oncol"},{"key":"2831_CR122","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/cancers13174495","volume":"13","author":"U Demkow","year":"2021","unstructured":"Demkow U. Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis. Cancers (Basel). 2021;13:4495. https:\/\/doi.org\/10.3390\/cancers13174495.","journal-title":"Cancers (Basel)"},{"key":"2831_CR123","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (80-). 2004;303:1532\u20135. https:\/\/doi.org\/10.1126\/science.1092385.","journal-title":"Science (80-)"},{"key":"2831_CR124","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/978-1-4939-9424-3_31","volume":"2019","author":"B Rada","year":"1982","unstructured":"Rada B. Neutrophil extracellular traps. Methods Mol Biol. 1982;2019:517\u201328. https:\/\/doi.org\/10.1007\/978-1-4939-9424-3_31.","journal-title":"Methods Mol Biol"},{"key":"2831_CR125","doi-asserted-by":"publisher","first-page":"7326","DOI":"10.1073\/pnas.1909546117","volume":"117","author":"HR Thiama","year":"2020","unstructured":"Thiama HR, Wong SL, Qiu R, Kittisopikul M, Vahabikashi A, Goldman AE, et al. NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin decondensation and nuclear envelope rupture. Proc Natl Acad Sci USA. 2020;117:7326\u201337. https:\/\/doi.org\/10.1073\/pnas.1909546117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2831_CR126","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-022-00345-3","volume":"11","author":"Y Chen","year":"2022","unstructured":"Chen Y, Hu H, Tan S, Dong Q, Fan X, Wang Y, et al. The role of neutrophil extracellular traps in cancer progression, metastasis and therapy. Exp Hematol Oncol. 2022;11:99. https:\/\/doi.org\/10.1186\/s40164-022-00345-3.","journal-title":"Exp Hematol Oncol"},{"key":"2831_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.718586","volume":"9","author":"T Tokuhiro","year":"2021","unstructured":"Tokuhiro T, Ishikawa A, Sato H, Takita S, Yoshikawa A, Anzai R, et al. Oxidized phospholipids and neutrophil elastase coordinately play critical roles in NET formation. Front Cell Dev Biol. 2021;9: 718586. https:\/\/doi.org\/10.3389\/fcell.2021.718586.","journal-title":"Front Cell Dev Biol"},{"key":"2831_CR128","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3389\/fimmu.2019.02313","volume":"10","author":"K Eghbalzadeh","year":"2019","unstructured":"Eghbalzadeh K, Georgi L, Louis T, Zhao H, Keser U, Weber C, et al. Compromised anti-inflammatory action of neutrophil extracellular traps in PAD4-deficient mice contributes to aggravated acute inflammation after myocardial infarction. Front Immunol. 2019;10:2313. https:\/\/doi.org\/10.3389\/fimmu.2019.02313.","journal-title":"Front Immunol"},{"key":"2831_CR129","doi-asserted-by":"publisher","first-page":"17864","DOI":"10.18632\/aging.203289","volume":"13","author":"C Fang","year":"2021","unstructured":"Fang C, Liu F, Wang Y, Yuan S, Chen R, Qiu X, et al. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer. Aging (Albany NY). 2021;13:17864\u201379. https:\/\/doi.org\/10.18632\/aging.203289.","journal-title":"Aging (Albany NY)"},{"key":"2831_CR130","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.3390\/ijms232112855","volume":"23","author":"J Schoen","year":"2022","unstructured":"Schoen J, Euler M, Schauer C, Schett G, Herrmann M, Knopf J, et al. Neutrophils\u2019 extracellular trap mechanisms: from physiology to pathology. Int J Mol Sci. 2022;23:12855. https:\/\/doi.org\/10.3390\/ijms232112855.","journal-title":"Int J Mol Sci"},{"key":"2831_CR131","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41467-022-28172-4","volume":"13","author":"AS Wilson","year":"2022","unstructured":"Wilson AS, Randall KL, Pettitt JA, Ellyard JI, Blumenthal A, Enders A, et al. Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2. Nat Commun. 2022;13:528. https:\/\/doi.org\/10.1038\/s41467-022-28172-4.","journal-title":"Nat Commun"},{"key":"2831_CR132","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","volume":"11","author":"MT Masucci","year":"2020","unstructured":"Masucci MT, Minopoli M, Del Vecchio S, Carriero MV. The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis. Front Immunol. 2020;11:1749. https:\/\/doi.org\/10.3389\/fimmu.2020.01749.","journal-title":"Front Immunol"},{"key":"2831_CR133","doi-asserted-by":"publisher","first-page":"5599660","DOI":"10.1155\/2023\/5599660","volume":"2023","author":"H Zuo","year":"2023","unstructured":"Zuo H, Yang M, Ji Q, Fu S, Pu X, Zhang X, et al. Targeting neutrophil extracellular traps: a novel antitumor strategy. J Immunol Res. 2023;2023:5599660. https:\/\/doi.org\/10.1155\/2023\/5599660.","journal-title":"J Immunol Res"},{"key":"2831_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100126","volume":"7","author":"LM Mauracher","year":"2023","unstructured":"Mauracher LM, Hell L, Moik F, Krall M, Englisch C, Roi\u00df J, et al. Neutrophils in lung cancer patients: activation potential and neutrophil extracellular trap formation. Res Pract Thromb Haemost. 2023;7: 100126. https:\/\/doi.org\/10.1016\/j.rpth.2023.100126.","journal-title":"Res Pract Thromb Haemost"},{"key":"2831_CR135","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00062.2021","volume":"103","author":"M Herre","year":"2023","unstructured":"Herre M, Cedervall J, Mackman N, Olsson AK. Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases. Physiol Rev. 2023;103:277\u2013312. https:\/\/doi.org\/10.1152\/physrev.00062.2021.","journal-title":"Physiol Rev"},{"key":"2831_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867516","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu F, Chen L, Fang C, Li S, Yuan S, et al. Neutrophil extracellular traps (NETs) promote non-small cell lung cancer metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway. Front Immunol. 2022;13: 867516. https:\/\/doi.org\/10.3389\/fimmu.2022.867516.","journal-title":"Front Immunol"},{"key":"2831_CR137","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2021.12.027","volume":"529","author":"S Ortiz-Espinosa","year":"2022","unstructured":"Ortiz-Espinosa S, Morales X, Senent Y, Alignani D, Tavira B, Macaya I, et al. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis. Cancer Lett. 2022;529:70\u201384. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.027.","journal-title":"Cancer Lett"},{"key":"2831_CR138","doi-asserted-by":"publisher","first-page":"pkz102","DOI":"10.1093\/JNCICS\/PKZ102","volume":"4","author":"JYY Wong","year":"2021","unstructured":"Wong JYY, Bassig BA, Loftfield E, Hu W, Freedman ND, Ji BT, et al. White blood cell count and risk of incident lung cancer in the UK Biobank. JNCI Cancer Spectr. 2021;4:pkz102. https:\/\/doi.org\/10.1093\/JNCICS\/PKZ102.","journal-title":"JNCI Cancer Spectr"},{"key":"2831_CR139","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-025-00731-z","volume":"13","author":"Z Liu","year":"2025","unstructured":"Liu Z, Dou Y, Lu C, Han R, He Y. Neutrophil extracellular traps in tumor metabolism and microenvironment. Biomark Res. 2025;13:12. https:\/\/doi.org\/10.1186\/s40364-025-00731-z.","journal-title":"Biomark Res"},{"key":"2831_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221: 107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"key":"2831_CR141","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/978-1-0716-2780-8_27","volume":"2588","author":"J Hirschfeld","year":"2023","unstructured":"Hirschfeld J, Chicca IJ, Moonen CGJ, White PC, Ling MR, Wright HJ, et al. Characterization, quantification, and visualization of neutrophil extracellular traps. Methods Mol Biol. 2023;2588:451\u201372. https:\/\/doi.org\/10.1007\/978-1-0716-2780-8_27.","journal-title":"Methods Mol Biol"},{"key":"2831_CR142","doi-asserted-by":"publisher","first-page":"7022337","DOI":"10.1155\/2023\/7022337","volume":"2023","author":"J Li","year":"2023","unstructured":"Li J, Chen J, Sun J, Li K. The formation of NETs and their mechanism of promoting tumor metastasis. J Oncol. 2023;2023:7022337. https:\/\/doi.org\/10.1155\/2023\/7022337.","journal-title":"J Oncol"},{"key":"2831_CR143","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-cancerbio-080421-015537","volume":"6","author":"XY He","year":"2022","unstructured":"He XY, Ng D, Egeblad M. Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer. Annu Rev Cancer Biol. 2022;6:223\u201343. https:\/\/doi.org\/10.1146\/annurev-cancerbio-080421-015537.","journal-title":"Annu Rev Cancer Biol"},{"key":"2831_CR144","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.freeradbiomed.2023.03.025","volume":"202","author":"M Jensen","year":"2023","unstructured":"Jensen M, Thorsen NW, Hallberg LAE, H\u00e4gglund P, Hawkins CL. New insight into the composition of extracellular traps released by macrophages exposed to different types of inducers. Free Radic Biol Med. 2023;202:97\u2013109. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.025.","journal-title":"Free Radic Biol Med"},{"key":"2831_CR145","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s12276-022-00784-2","volume":"54","author":"SB Kwak","year":"2022","unstructured":"Kwak SB, Kim SJ, Kim J, Kang YL, Ko CW, Kim I, et al. Tumor regionalization after surgery: roles of the tumor microenvironment and neutrophil extracellular traps. Exp Mol Med. 2022;54:720\u20139. https:\/\/doi.org\/10.1038\/s12276-022-00784-2.","journal-title":"Exp Mol Med"},{"key":"2831_CR146","doi-asserted-by":"publisher","first-page":"8316525","DOI":"10.1155\/2022\/8316525","volume":"2022","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yi H, Chen J, Li H, Luo Y, Cheng T, et al. Neutrophil extracellular traps facilitate A549 cell invasion and migration in a macrophage-maintained inflammatory microenvironment. Biomed Res Int. 2022;2022:8316525. https:\/\/doi.org\/10.1155\/2022\/8316525.","journal-title":"Biomed Res Int"},{"key":"2831_CR147","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","volume":"79","author":"L Cristinziano","year":"2022","unstructured":"Cristinziano L, Modestino L, Antonelli A, Marone G, Simon HU, Varricchi G, et al. Neutrophil extracellular traps in cancer. Semin Cancer Biol. 2022;79:91\u2013104. https:\/\/doi.org\/10.1016\/j.semcancer.2021.07.011.","journal-title":"Semin Cancer Biol"},{"key":"2831_CR148","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00262-022-03248-8","volume":"72","author":"SJ Ralph","year":"2023","unstructured":"Ralph SJ, Reynolds MJ. Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors. Cancer Immunol Immunother. 2023;72:527\u201342. https:\/\/doi.org\/10.1007\/s00262-022-03248-8.","journal-title":"Cancer Immunol Immunother"},{"key":"2831_CR149","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ijc.30671","volume":"140","author":"CR Millrud","year":"2017","unstructured":"Millrud CR, K\u00e5gedal \u00c5, Kumlien Geor\u00e9n S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557\u201367. https:\/\/doi.org\/10.1002\/ijc.30671.","journal-title":"Int J Cancer"},{"key":"2831_CR150","doi-asserted-by":"publisher","first-page":"1075260","DOI":"10.3389\/fimmu.2022.1075260","volume":"13","author":"Q Fang","year":"2022","unstructured":"Fang Q, Stehr AM, Naschberger E, Knopf J, Herrmann M, St\u00fcrzl M. No NETs no TIME: crosstalk between neutrophil extracellular traps and the tumor immune microenvironment. Front Immunol. 2022;13:1075260. https:\/\/doi.org\/10.3389\/fimmu.2022.1075260.","journal-title":"Front Immunol"},{"key":"2831_CR151","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-024-01982-9","volume":"10","author":"R Zhai","year":"2024","unstructured":"Zhai R, Gong Z, Wang M, Ni Z, Zhang J, Wang M, et al. Neutrophil extracellular traps promote invasion and metastasis via NLRP3-mediated oral squamous cell carcinoma pyroptosis inhibition. Cell Death Discov. 2024;10:214. https:\/\/doi.org\/10.1038\/s41420-024-01982-9.","journal-title":"Cell Death Discov"},{"key":"2831_CR152","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24:299\u2013315. https:\/\/doi.org\/10.1038\/s41568-024-00674-x.","journal-title":"Nat Rev Cancer"},{"key":"2831_CR153","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/onc.2016.406","volume":"36","author":"L Erpenbeck","year":"2017","unstructured":"Erpenbeck L, Sch\u00f6n MP. Neutrophil extracellular traps: protagonists of cancer progression? Oncogene. 2017;36:2483\u201390. https:\/\/doi.org\/10.1038\/onc.2016.406.","journal-title":"Oncogene"},{"key":"2831_CR154","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science (80-). 2018;361:eaao4227. https:\/\/doi.org\/10.1126\/science.aao4227.","journal-title":"Science (80-)"},{"key":"2831_CR155","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5582\/bst.2019.01326","volume":"13","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liu L. The pro-tumor effect and the anti-tumor effect of neutrophils extracellular traps. Biosci Trends. 2019;13:469\u201375. https:\/\/doi.org\/10.5582\/bst.2019.01326.","journal-title":"Biosci Trends"},{"key":"2831_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PCBI.1008257","volume":"17","author":"J Lee","year":"2021","unstructured":"Lee J, Lee D, Lawler S, Kim Y. Role of neutrophil extracellular traps in regulation of lung cancer invasion and metastasis: structural insights from a computational model. PLoS Comput Biol. 2021;17: e1008257. https:\/\/doi.org\/10.1371\/JOURNAL.PCBI.1008257.","journal-title":"PLoS Comput Biol"},{"key":"2831_CR157","doi-asserted-by":"publisher","first-page":"1470620","DOI":"10.3389\/fimmu.2024.1470620","volume":"15","author":"J Dimitrov","year":"2024","unstructured":"Dimitrov J, Maddalena M, Terlizzi C, Altobelli GG, Pellegrino S, Mehmood T, et al. Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells. Front Immunol. 2024;15:1470620. https:\/\/doi.org\/10.3389\/fimmu.2024.1470620.","journal-title":"Front Immunol"},{"key":"2831_CR158","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12013-024-01549-6","volume":"83","author":"J Xu","year":"2024","unstructured":"Xu J, Zhang H, Yang L. Rab3B proteins: cellular functions, regulatory mechanisms, and potential as a cancer therapy target. Cell Biochem Biophys. 2024;83:263\u201377. https:\/\/doi.org\/10.1007\/s12013-024-01549-6.","journal-title":"Cell Biochem Biophys"},{"key":"2831_CR159","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.18632\/oncotarget.3575","volume":"6","author":"J Yang","year":"2015","unstructured":"Yang J, Liu W, Lu X, Fu Y, Li L, Luo Y. High expression of small GTPase Rab3D promotes cancer progression and metastasis. Oncotarget. 2015;6:11125\u201338. https:\/\/doi.org\/10.18632\/oncotarget.3575.","journal-title":"Oncotarget"},{"key":"2831_CR160","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jcb.29948","volume":"122","author":"RD Raffaniello","year":"2021","unstructured":"Raffaniello RD. Rab3 proteins and cancer: Exit strategies. J Cell Biochem. 2021;122:1295\u2013301. https:\/\/doi.org\/10.1002\/jcb.29948.","journal-title":"J Cell Biochem"},{"key":"2831_CR161","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61:194\u2013211. https:\/\/doi.org\/10.1007\/s12016-020-08804-7.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2831_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250265","volume":"16","author":"H Hayden","year":"2021","unstructured":"Hayden H, Ibrahim N, Klopf J, Zagrapan B, Mauracher LM, Hell L, et al. ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo. PLoS ONE. 2021;16: e0250265. https:\/\/doi.org\/10.1371\/journal.pone.0250265.","journal-title":"PLoS ONE"},{"key":"2831_CR163","first-page":"425","volume-title":"Methods in molecular biology","author":"N de Buhr","year":"2020","unstructured":"de Buhr N, von K\u00f6ckritz-Blickwede M. Detection, visualization, and quantification of neutrophil extracellular traps (NETs) and NET markers. In: Quinn MT, DeLeo FR, editors. Methods in molecular biology, vol. 2087. New York, NY: Springer US; 2020. p. 425\u201342."},{"key":"2831_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.647","volume":"5","author":"Y Ma","year":"2024","unstructured":"Ma Y, Wei J, He W, Ren J. Neutrophil extracellular traps in cancer. MedComm. 2024;5: e647. https:\/\/doi.org\/10.1002\/mco2.647.","journal-title":"MedComm"},{"key":"2831_CR165","doi-asserted-by":"publisher","first-page":"1610899","DOI":"10.3389\/pore.2023.1610899","volume":"29","author":"Y Zuo","year":"2023","unstructured":"Zuo Y, Leng G, Leng P. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps. Pathol Oncol Res. 2023;29:1610899. https:\/\/doi.org\/10.3389\/pore.2023.1610899.","journal-title":"Pathol Oncol Res"},{"key":"2831_CR166","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2174\/0113862073282003240119064337","volume":"27","author":"G Mo","year":"2024","unstructured":"Mo G, Long X, Cao L, Tang Y, Yan Y, Guo T. A six-gene prognostic model based on neutrophil extracellular traps (NETs)-related gene signature for lung adenocarcinoma. Comb Chem High Throughput Screen. 2024;27:1969\u201383. https:\/\/doi.org\/10.2174\/0113862073282003240119064337.","journal-title":"Comb Chem High Throughput Screen"},{"key":"2831_CR167","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004210","volume":"10","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Guo L, Dai Q, Shang B, Xiao T, Di X, et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. J Immunother Cancer. 2022;10: e004210. https:\/\/doi.org\/10.1136\/jitc-2021-004210.","journal-title":"J Immunother Cancer"},{"key":"2831_CR168","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13046-021-02013-6","volume":"40","author":"D Yang","year":"2021","unstructured":"Yang D, Liu J. Neutrophil extracellular traps: a new player in cancer metastasis and therapeutic target. J Exp Clin Cancer Res. 2021;40:233. https:\/\/doi.org\/10.1186\/s13046-021-02013-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"2831_CR169","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2020.04.009","volume":"52","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Oliver TG. Neutrophils create an ImpeNETrable shield between tumor and cytotoxic immune cells. Immunity. 2020;52:729\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.009.","journal-title":"Immunity"},{"key":"2831_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.714357","volume":"11","author":"BZ Shao","year":"2021","unstructured":"Shao BZ, Yao Y, Li JP, Chai NL, Linghu EQ. The role of neutrophil extracellular traps in cancer. Front Oncol. 2021;11: 714357. https:\/\/doi.org\/10.3389\/fonc.2021.714357.","journal-title":"Front Oncol"},{"key":"2831_CR171","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/biomedicines12081831","volume":"12","author":"S Horaguchi","year":"2024","unstructured":"Horaguchi S, Nakahara Y, Igarashi Y, Kouro T, Wei F, Murotani K, et al. Prognostic significance of plasma neutrophil extracellular trap levels in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. Biomedicines. 2024;12:1831. https:\/\/doi.org\/10.3390\/biomedicines12081831.","journal-title":"Biomedicines"},{"key":"2831_CR172","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/2211-5463.13499","volume":"14","author":"D Chen","year":"2024","unstructured":"Chen D, Liang H, Huang L, Zhou H, Wang Z. Liraglutide enhances the effect of checkpoint blockade in lung and liver cancers through the inhibition of neutrophil extracellular traps. FEBS Open Bio. 2024;14:1365\u201377. https:\/\/doi.org\/10.1002\/2211-5463.13499.","journal-title":"FEBS Open Bio"},{"key":"2831_CR173","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10495-024-01947-4","volume":"29","author":"AX Han","year":"2024","unstructured":"Han AX, Long BY, Li CY, Di HD, Xiong EQ, Li FJ, et al. Machine learning framework develops neutrophil extracellular traps model for clinical outcome and immunotherapy response in lung adenocarcinoma. Apoptosis. 2024;29:1090\u2013108. https:\/\/doi.org\/10.1007\/s10495-024-01947-4.","journal-title":"Apoptosis"},{"key":"2831_CR174","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01170-1","author":"L Xing","year":"2024","unstructured":"Xing L, Wu S, Xue S, Li X. A novel neutrophil extracellular trap signature predicts patient chemotherapy resistance and prognosis in lung adenocarcinoma. Mol Biotechnol. 2024. https:\/\/doi.org\/10.1007\/s12033-024-01170-1.","journal-title":"Mol Biotechnol"},{"key":"2831_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100556","volume":"4","author":"C Li","year":"2023","unstructured":"Li C, Wu J, Zhang L, Wang F, Xu L, Zhao Y, et al. Brief Report: acetaminophen reduces neoadjuvant chemoimmunotherapy efficacy in patients with NSCLC by promoting neutrophil extracellular trap formation: analysis from a phase 2 clinical trial. JTO Clin Res Rep. 2023;4: 100556. https:\/\/doi.org\/10.1016\/j.jtocrr.2023.100556.","journal-title":"JTO Clin Res Rep"},{"key":"2831_CR176","doi-asserted-by":"publisher","first-page":"2279754","DOI":"10.1080\/07853890.2023.2279754","volume":"55","author":"H Wang","year":"2023","unstructured":"Wang H, Shi Y, Xu X, Xu S, Shi Y, Chen W, et al. A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma. Ann Med. 2023;55:2279754. https:\/\/doi.org\/10.1080\/07853890.2023.2279754.","journal-title":"Ann Med"},{"key":"2831_CR177","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.3390\/ijms24054896","volume":"24","author":"U Demkow","year":"2023","unstructured":"Demkow U. Molecular mechanisms of neutrophil extracellular trap (NETs) degradation. Int J Mol Sci. 2023;24:4896. https:\/\/doi.org\/10.3390\/ijms24054896.","journal-title":"Int J Mol Sci"},{"key":"2831_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.142957","volume":"466","author":"Y Hao","year":"2023","unstructured":"Hao Y, Li X, Liu Y, Liu D, Zhao X, Ji S, et al. Manganese doped nanosystem for degrading neutrophil extracellular traps and improving chemotherapy efficiency to synergistically inhibit lung metastasis of breast cancer. Chem Eng J. 2023;466: 142957. https:\/\/doi.org\/10.1016\/j.cej.2023.142957.","journal-title":"Chem Eng J"},{"key":"2831_CR179","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.3390\/ijms23169134","volume":"23","author":"CJ Chen","year":"2022","unstructured":"Chen CJ, Wu CC, Chang CY, Li JR, Ou YC, Chen WY, et al. Metformin mitigated obesity-driven cancer aggressiveness in tumor-bearing mice. Int J Mol Sci. 2022;23:9134. https:\/\/doi.org\/10.3390\/ijms23169134.","journal-title":"Int J Mol Sci"},{"key":"2831_CR180","unstructured":"Center JGBC, editor. Beta-glucan\u2019s immuno-modulatory effect on non-small cell lung cancer. 2008."},{"key":"2831_CR181","unstructured":"Systems VM, editor. Fresolimumab and stereotactic ablative radiotherapy in early stage non-small cell lung cancer. 2015."},{"key":"2831_CR182","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","volume":"42","author":"AJ Armstrong","year":"2024","unstructured":"Armstrong AJ, Geva R, Chung HC, Lemech C, Miller WH, Hansen AR, et al. CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investig New Drugs. 2024;42:145\u201359. https:\/\/doi.org\/10.1007\/s10637-023-01410-2.","journal-title":"Investig New Drugs"},{"key":"2831_CR183","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.45446","volume":"5","author":"DW Blayney","year":"2022","unstructured":"Blayney DW, Mohanlal R, Adamchuk H, Kirtbaya DV, Chen M, Du L, et al. Efficacy of plinabulin vs pegfilgrastim for prevention of docetaxel-induced neutropenia in patients with solid tumors: a randomized clinical trial. JAMA Netw Open. 2022;5: e2145446. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.45446.","journal-title":"JAMA Netw Open"},{"key":"2831_CR184","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s2213-2600(24)00178-4","volume":"12","author":"B Han","year":"2024","unstructured":"Han B, Feinstein T, Shi Y, Chen G, Yao Y, Hu C, et al. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respir Med. 2024;12:775\u201386. https:\/\/doi.org\/10.1016\/s2213-2600(24)00178-4.","journal-title":"Lancet Respir Med"},{"key":"2831_CR185","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1200\/jco.2014.32.15_suppl.8054","volume":"32","author":"RS Heist","year":"2014","unstructured":"Heist RS, Aren OR, Mita AC, Polikoff J, Bazhenova L, Lloyd GK, et al. Randomized phase 2 trial of plinabulin (NPI-2358) plus docetaxel in patients with advanced non-small cell lung cancer (NSCLC). J Clin Oncol. 2014;32:8054\u20138054. https:\/\/doi.org\/10.1200\/jco.2014.32.15_suppl.8054.","journal-title":"J Clin Oncol"},{"key":"2831_CR186","unstructured":"Genentech I, editor. A multicenter, open label, randomized study of AMG 951 in subjects with previously untreated stage IIIb\/IV non-small cell lung cancer (NSCLC) treated with chemotherapy with or without bevacizumab. 2007."},{"key":"2831_CR187","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23033","volume":"2","author":"RH Vonderheide","year":"2013","unstructured":"Vonderheide RH, Burg JM, Mick R, Trosko JA, Li D, Shaik MN, et al. Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors. Oncoimmunology. 2013;2: e23033. https:\/\/doi.org\/10.4161\/onci.23033.","journal-title":"Oncoimmunology"},{"key":"2831_CR188","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lungcan.2007.12.011","volume":"61","author":"FA Greco","year":"2008","unstructured":"Greco FA, Bonomi P, Crawford J, Kelly K, Oh Y, Halpern W, et al. Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer. Lung Cancer. 2008;61:82\u201390. https:\/\/doi.org\/10.1016\/j.lungcan.2007.12.011.","journal-title":"Lung Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02831-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:03:30Z","timestamp":1751555010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02831-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":188,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2831"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02831-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"266"}}